[Changes in plasma lipids and lipoproteins in chronic liver diseases].
In 214 patients with different chronic liver diseases and in 31 controls the plasma lipids (total and esterified cholesterol, HDL cholesterol, triglycerides) and lipoproteins have been evaluated. The liver patients were classified not only according to traditional diagnostic criteria, but also using a functional classification based on the evaluation of biosynthetic alteration and cholestatic damage, separately assessed in all patients. Parenchimal liver diseases and cholestatic diseases show different and specific plasma lipids and lipoprotein abnormalities. In parenchimal diseases (notably cirrhosis) a reduction of the plasmatic level of total, esterified and HDL cholesterol, without significant changes of triglycerides and lipoproteins was observed. As documented by functional classification, the reduction of total and esterified cholesterol correlates significantly with the degree of biosynthetic alteration. This finding may be related to the reduced hepatic cholesterol synthesis, probably associated with a decreased serum activity of the lecithin cholesterol acyl transferase (LCAT), due to impaired hepatic enzyme synthesis.
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D002788:Cholesterol Esters / Q000097:blood; D008076:Cholesterol, HDL; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008107:Liver Diseases / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
D002788:Cholesterol Esters; D008076:Cholesterol, HDL; D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D014280:Triglycerides; D002784:Cholesterol
Studio delle alterazioni dei lipidi e delle lipoproteine plasmatiche nelle epatopatie chroniche.